English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT04661137 /

KARYOPHARM-IST-318-2020-0369

A Phase 2B Study Of Selinexor (KPT-330), In Combination With Carfilzomib, Daratumumab Or Pomalidomide In Patients With Multiple Myeloma Relapsing On Current Therapy

DISEASE GROUP:
Multiple Myeloma
current phase:
Phase II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: